• Title of article

    Development and efficacy of tryptophol-containing emulgel for reducing subcutaneous fungal nodules from Scedosporium apiospermum eumycetoma

  • Author/Authors

    Kitisin ، Thitinan Department of Microbiology and Immunology - Faculty of Tropical Medicine - Mahidol University , Muangkaew ، Watcharamat Department of Microbiology and Immunology - Faculty of Tropical Medicine - Mahidol University , Ampawong ، Sumate Department of Tropical Pathology - Faculty of Tropical Medicine - Mahidol University , Sansurin ، Nichapa Northeast Laboratory Animal Center - Khon Kaen University , Thitipramote ، Natthawut Center of Excellence in Natural Products Innovation - Mae Fah Luang University , Sukphopetch ، Passanesh Department of Microbiology and Immunology - Faculty of Tropical Medicine - Mahidol University

  • From page
    707
  • To page
    722
  • Abstract
    Background and purpose: Subcutaneous infections caused by Scedosporium apiospermum present as chronic eumycetomatous manifestations in both immunocompromised and immunocompetent individuals. Serious adverse effects/toxicities from the long-term use of antifungal drugs and antifungal resistance have been reported in patients with S. apiospermum infections. The present study aimed to determine the anti-S. apiospermum activities of fungal quorum sensing molecule known as tryptophol (TOH) and to develop a TOHcontaining emulgel for treating S. apiospermum eumycetoma. Experimental approach: Anti-S. apiospermum activities of TOH were determined and compared with voriconazole. Effects of TOH on S. apiospermum biofilm formation and human foreskin fibroblast (HFF)-1 cell cytotoxicity were determined. Moreover, TOH-containing emulgel was developed and physical properties, in vitro, and in vivo antifungal activities against S. apiospermum eumycetoma were evaluated. Findings/Results: The minimal concentration of TOH at 100 μM exhibited anti-S. apiospermum activities by reducing growth rate, germination rate, and biofilm formation with less cytotoxicity to HFF-1 cells than voriconazole. Further study on the development of an emulgel revealed that TOH-containing emulgel exhibited excellent physical properties including homogeneity, consistency, and stability. Treatment by TOH-containing emulgel significantly reduced subcutaneous mass in a mouse model of S. apiospermum eumycetoma. The histopathological assessment showed marked improvement after 14 days of TOH-containing emulgel treatment. Conclusion and implications: TOH could be used as an anti-fungal agent against S. apiospermum infections. A novel and stable TOH-containing emulgel was developed with excellent anti-S. apiospermum activities suggesting the utilization of TOH-containing emulgel as an innovative therapeutic approach in the treatment of S. apiospermum eumycetoma.
  • Keywords
    Emulgel , Eumycetoma , Quorum sensing molecule, Scedosporium apiospermum , Tryptophol
  • Journal title
    Research in Pharmaceutical Sciences
  • Journal title
    Research in Pharmaceutical Sciences
  • Record number

    2735646